Effect of cyclic AMP on lipid accumulation and metabolism in human atherosclerotic aortic cells.
Atherogenicity of blood serum from patients with coronary heart disease.
Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta.
[Carbohydrate composition of native and desialylated low density lipoproteins in the plasma of patients with coronary atherosclerosis]
Lipid-laden white blood cells in the circulation of patients with coronary heart disease.
[The effect of calcium antagonists on cholesterol metabolism in human aortal intima cells and macrophage lines]
Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
Intracellular Cholesterol Retention—New Target for Direct Anti-Atherosclerotic Therapy: Open Journal of Endocrine and Metabolic Diseases
In vitro models of antiatherosclerotic effects of cardiovascular drugs: The American Journal of Cardiology
The reduction of estimated cardiovascular risk with Allicor: Atherosclerosis
Deglycosylation is an atherogenic modification of ApoB-containing lipoproteins: Atherosclerosis
Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins: Biochemical and Biophysical Research Communications
Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin: International Journal of Cardiology
Deglycosilation is an atherogenic modification of apo-b-containing lipoproteins: Atherosclerosis
The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease: Lipids in Health and Disease
Heterogeneity of human aortic cells in regard to RNA content.
Primary cultures of enzyme-isolated cells from normal and atherosclerotic human aorta.
Dissociated cells from different layers of adult human aortic wall.
Enzymatic detoxication of superoxide anion-radicals and lipoperoxides in intima and media of atherosclerotic aorta.
[Study of the structural and functional properties of fibronectin--a high molecular weight plasma glycoproteins--by using monoclonal antibodies]
[Determination of the lipid content of a single cell by flow cytofluorometry]
[Decrease in the lipid content of human atherosclerotic aorta cells as affected by compounds increasing the intracellular level of cyclic AMP]
[Immunomorphological study of fibronectin localization in a primary human aorta cell culture]
Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells.
Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta.
Artificial HDL as an anti-atherosclerotic drug.
LDL apheresis and regression of atherosclerosis.
Primary RIA screening of hybridoma supernatants without use of a negative control.
Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme-isolated and cultured cells.
[Cellular composition and biochemical characteristics of the human aorta]
Direct anti-atherosclerotic therapy preventing intracellular cholesterol retention: Health
Cyclophilins in atherosclerosis: a new therapeutic target?
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy.
Association of mitochondrial genetic variation with carotid atherosclerosis.
Effects of garlic on atherosclerosis: Nutrition
Lipid regulators during atherogenesis: expression of LXR, PPAR, and SREBP mRNA in the human aorta.
Increased shedding of microvesicles from intimal smooth muscle cells in athero-prone areas of the human aorta: implications for understanding of the predisease stage.
Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis.
Direct anti-atherosclerotic therapy; development of natural anti-atherosclerotic drugs preventing cellular cholesterol retention.
Lipids in cells of atherosclerotic and uninvolved human aorta. II. Lipid metabolism in primary culture.
[Concentration of erythrocyte-based magnetic carriers in the vascular bed]
Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
Novel monocyte biomarkers of atherogenic conditions.
Determination of total intracellular lipid content by flow cytofluorometry.
Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications.
Monoclonal antibody reveals heterogeneity in human aortic intima: detection of a ganglioside antigen associated with a subpopulation of intimal cells.
Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents.
Cyclic AMP and cyclic GMP content in a short-term organ culture of normal and atherosclerotic human aorta.
Adult human aortic cells in primary culture: heterogeneity in shape.
[Effects of beta adrenergic blocking agents and calcium antagonists on atherogenic properties of blood serum of patients with ischemic heart disease]
Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis.
[Aggregates of modified low density lipoproteins indicate accumulation of lipids in human aortic intima cells in vitro]
[Desialylated low density lipoproteins--atherogenic lipoproteins occurring in blood of patients with coronary atherosclerosis]
[Blood lipophages in patients with ischemic heart disease]
In vitro models of anti-atherosclerotic effects of cardiovascular drugs.
[Isolation of desialylated low density lipoproteins from the blood of patients with ischemic heart disease by affinity chromatography]
Quantitative estimation of lipid-laden cells in atherosclerotic lesions of the human aorta.
[Effect of radiation-protective preparations on the level of cyclic adenosine-3',5'-monophosphate (cycl AMP), adenylate cyclase and cycl AMP phosphodiesterase]
Mitochondrial mutations are associated with atherosclerotic lesions in the human aorta.
[Effect of ionizing radiation on the activity of adenylate cyclase, cAMP phosphodiesterase and the level of cAMP in mouse liver]
Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: Separation from native lipoprotein by affinity chromatography: Biochemical and Biophysical Research Communications
[Study of intima-medial thickness (IMT) of the carotid arteries as an indicator of natural atherosclerosis progress in Moscow population].
[Post-radiation disorders in the cyclic AMP system of mouse spleen and thymus lymphoid cells]
[Dendritic cells and their role in immune reactions of atherosclerosis].
[Cultured cell systems for revelation of new drugs antiatherosclerotic effects and their mechanisms investigation].
[Role of endogenous substances in developing a basis for increased radiation resistance. 4. Effect of serotonin on lipid radiation sensitizers]
[Role of endogenic substances in creating a background of increased radioresistance. 3. The role of endogenic serotonin]
[Role of endogenous substances in the creation of a background of increased radioresistance. Report 7. Study of the influence of dopamine and histamine on lipid radiosensitizers]
Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture: Atherosclerosis
[A method of determining adenylate cyclase activity]
Effects of Calcium Antagonists, β-Blockers, and Nitrates on Atherosclerotic Characteristics of Human Aortic Cells: Journal of Cardiovascular Pharmacology
Mutation C3256T of mitochondrial genome in white blood cells: novel genetic marker of atherosclerosis and coronary heart disease.
[RNA content of cells isolated from normal and arteriosclerotic human aorta]
Correlation between lipid deposition, immune-inflammatory cell content and MHC class II expression in diffuse intimal thickening of the human aorta.
[Polymorphism of human aortic cells in culture]
Lipid-Lowering Effects of Time-Released Garlic Powder Tablets in Double-Blinded Placebo-Controlled Randomized Study: Journal of Atherosclerosis and Thrombosis
Contents of mRNAs encoding endosome/lysosome components in normal human aorta and in stage II of atherogenesis: a hidden regulation.
Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta.
[Lipid metabolism in cells of human atherosclerotic aorta. Study in the primary culture]
[Numbers of cells and cell proliferation in intima of different human arteries].
[Variability of intima-media thickness of the common carotid arteries in Moscow city population without clinical symptoms of atherosclerosis].
Musashi-1 expression in atherosclerotic arteries and its relevance to the origin of arterial smooth muscle cells: histopathological findings and speculations.
[A new method of quantitative estimation of mutant allele in mitochondrial genome].
Lipoprotein immune complexes as markers of atherosclerosis.
Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation.
Cholesterol level in circulating immune complexes as a marker of coronary atherosclerosis.
[Structure of the neointima after balloon catheter injury of the rabbit aorta in the context of hypercholesterolemia: analysis of endothelial influence on lipid accumulation].
[Changes in the 3-dimensional organization of the cellular system of the human aortic intima in atherosclerosis]
Antibody-like immunoglobulins G against low density lipoprotein that stimulate lipid accumulation in cultured cells.
[The cholesterol content in immune complexes as a marker of coronary and peripheral atherosclerosis]
Lipids in cells of atherosclerotic and uninvolved human aorta. III. Lipid distribution in intimal sublayers.
Use of human atherosclerotic cells for optimization of antiatherosclerotic therapy.
Atherogenicity of autoantibodies against low density lipoprotein.
The interaction of plasma sialylated and desialylated lipoproteins with collagen from the intima and media of uninvolved and atherosclerotic human aorta.
Desialylated low density lipoprotein - naturally occurring modified lipoprotein with atherogenic potency: Atherosclerosis
Primary RIA screening of hybridoma supernatants without use of a negative control: Journal of Immunological Methods
Decreased expression of liver X receptor-α in macrophages infected with Chlamydia pneumoniae in human atherosclerotic arteries in situ.
Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content.
Anti-Atherosclerotic Therapy Based on Botanicals: Recent Patents on Cardiovascular Drug Discovery
The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease.
[Effect of dibutyryl-cAMP on the cholesterol ester content in human atherosclerotic aorta cells]
Peculiarities of cell composition and cell proliferation in different type atherosclerotic lesions in carotid and coronary arteries.
[Use of perilenoyl-labelled triglyceride as a fluorescent probe for staining lipid inclusions in cultured cells]
Direct Anti-atherosclerosis-related Effects of Garlic: Annals of Medicine
[Content of lipids in cells, isolated from normal and atherosclerotically-altered portions of the human aorta]
Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential: BioFactors
[Detection of 2 cell subpopulations each differing in incorporating low-density lipoproteins in an atherosclerotic plaque from the human aorta]
Stellate cells in the intima of human aorta. Application of alkaline dissociation method in the analysis of the vessel wall cellular content.
Regression of atherosclerotic manifestations in primary culture of human aortic cells: effects of prostaglandins.
[Immunomorphological study of the localization of types I, III, IV and V collagen in a primary culture of human aortic cells]
Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension.
Prostacyclin analogues as antiatherosclerotic drugs.
Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome.
[3H-thymidine incorporation into human aorta cells in primary culture. An autoradiographic study]
Deglycosylation of apo B-containing lipoproteins increase their ability to aggregate and to promote intracellular cholesterol accumulation in vitro.
Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture.
Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study.
Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease
Antiatherogenic and antiatherosclerotic effects of mushroom extracts revealed in human aortic intima cell culture: Drug Development Research
Comparative contents of mRNAs of sex steroid receptors and enzymes of their metabolism in arterial walls of men.
Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study.
Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine: Atherosclerosis
Use of natural products in anticytokine therapy.
Diagnostic value of immune cholesterol as a marker for atherosclerosis
[Circulating immune complex cholesterol as a biochemical marker of coronary atherosclerosis]
[Relations between the levels of lipoprotein-containing immune complexes and lipids in the blood of patients with ischemic heart disease]
[The cellular polymorphism of the myointimal thickening in the rabbit aorta].
Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.
Use of cultured atherosclerotic cells for investigation of antiatherosclerotic effects of anipamil and other calcium antagonists.
[Seasonal variations of the lipid spectrum in patients with post-infarction cardiosclerosis and arterial hypertension]
Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta.
[Atherogenic effect of beta-blocker propranolol revealed in the rabbit denudated aorta]
Synergetic effect of desialylated and glycated low density lipoproteins on cholesterol accumulation in cultured smooth muscle intimal cells.
[Combined effects of desialylated and glycosylated low density lipoproteins on lipid content of human aortic intima cells in vitro]
Stellate cells of aortic intima: II. Arborization of intimal cells in culture.
Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil.
Influence of a cholesterol rich diet in rabbits on the formation of PGI2 and TXA2.
Stellate cells of aortic intima: I. Human and rabbit.
[Atherogenic properties of sera and low-density lipoproteins in patients with diabetes mellitus]
[The structure of the endothelialized and nonendothelialized areas of myointimal thickening of the rabbit aorta].
[Elimination of the atherogenic effect of beta blocker propranolol by papaverine]
Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation in human aortic intimal cells--the role of lipoprotein aggregation.
Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.
[Comparison between seasonal changes in lipid indicators in patients with post-infarction cardiosclerosis and arterial hypertension in Ashkhabad and Moscow]
Mitochondrial dysfunction and mitochondrial DNA mutations in atherosclerotic complications in diabetes.
Monocytes as a diagnostic marker of cardiovascular diseases.
Widespread distribution of HLA-DR-expressing cells in macroscopically undiseased intima of the human aorta: a possible role in surveillance and maintenance of vascular homeostasis.
[Cholesterol of circulating immune complexes as biomarker of atherosclerosis].
METHOD FOR DETECTION OF PREDISPOSITION TO ATHEROSCLEROSIS, CORONARY HEART DISEASE AND RELATED CONDITIONS
METHOD FOR TREATING MASTOPATHY
Pluronic block copolymers inhibit low density lipoprotein self-association.
Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine.
Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation.
[Atherogenic properties of phenothiazine drugs manifesting in cultured cells of the human aortic intima]
[Effects of lovastatin therapy on the level of low density lipoproteins and atherogenic potential of serum in patients with ischemic heart disease and hypercholesterolemia]
Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation.
The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta.
Optimization of the assay for sialic acid determination in low density lipoprotein.
[The identification of pericyte-like cells in the subendothelium of human blood vessels]
Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions.
Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.
Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.
[New prospects for the treatment of atherosclerosis: garlic preparations]
Continuous subendothelial network formed by pericyte-like cells in human vascular bed.
Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin.
The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells.
Intracellular cholesterol accumulation is accompanied by enhanced proliferative activity of human aortic intimal cells.
Are all low-density lipoprotein particles partially desialylated in plasma?
Prostacyclin, thromboxane A2 and calcium antagonists: effects on atherosclerotic characteristics of vascular cells.
The effects of eicozanoids and lipoxygenase inhibitors on the lipid metabolism of aortic cells.
Cyclic nucleotides and atherosclerosis: studies in primary culture of human aortic cells.
Prevention of experimental carotid artery thrombosis by magnetic vectoring of aspirin.
The gangliosides of adult human aorta: intima, media and plaque.
Spontaneous atherosclerotic plaque and obstruction of distal anastomosis in femoral artery. Comparative morphologic study.
[Decreased lipid levels in arteriosclerotic plaques of the human aorta after LDL-apheresis (an in vitro study)]
[Effect of components of the extracellular matrix on the accumulation of lipids in human cells]
Diabetes mellitus and atherosclerosis.
[Effect of the garlic tablets allicor on thrombocyte aggregation in vitro and ex vivo]
In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells.
Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro.
Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential.
Effects of garlic on atherosclerosis.
[Localization of collagen-synthesizing cells in normal and atherosclerotic intima of human aorta]
Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta.
[Lipid composition of polymodified (desialylated) low density lipoproteins]
Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein.
Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
[The effect of eicosapentaenoic acid and various prostaglandins on cholesterol accumulation and proliferation of intima cells from human aorta]
[The effect of glucagon and concanavalin A on cholesterol accumulation in mouse peritoneal macrophages and human aorta intima cells]
[Lysosomal proteinases of the human aortal intima and atherogenesis]
[Effect of lipostabil on cholesterol levels in atherosclerotic plaques of the human aorta and the aggregative capacity of thrombocytes (in vitro study)]
Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells.
Atherogenic effects of beta blockers on cells cultured from normal and atherosclerotic aorta.
Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination.
Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression.
Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists.
[Cholesterol-containing circulating immune complexes--a component of the blood serum in patients with ischemic heart disease that determines its atherogenic properties]
[Low-density lipoproteins with different capacity for aggregation]
[Allicor efficacy in lowering the risk of ischemic heart disease in primary prophylaxis]
Resistance of native and circulating modified low-density lipoproteins in human blood to association.
[Reduction of cardiovascular risk in primary prophylaxy of coronary heart disease]
Phospholipid hydrolysis with phospholipases A2 and C impairs apolipoprotein B-100 conformation on the surface of low density lipoproteins by reducing their association resistance.
Proteolysis of apoprotein B-100 impairs its topography on LDL surface and reduces LDL association resistance.
[A comparative study of the lipid phase in native and circulating multiple-modified low-density lipoproteins of human blood by the use of the spin probe method]
Desialylation decreases the resistance of apo B-containing lipoproteins to aggregation and increases their atherogenic potential.
Oxidation-induced aggregation of LDL increases their uptake by smooth muscle cells from human aorta.
[Use of allicor to lower the risk of myocardial infarction]
Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins.
Antiatherogenic effect of grape flavonoids in an ex vivo model.
Ganglioside content and composition of cells from normal and atherosclerotic human aorta.
Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients.
[Atherogenic properties of beta adrenergic blockaders evident on vascular wall cells]
Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells.
[Effect of medicinal leech preparations on indicators of atherogenesis]
[The content of cyclic nucleotides in an organ culture of normal and atherosclerosis-affected human aorta]
Neutral glycolipids of atherosclerotic plaques and unaffected human aorta tissue.
Use of lipophilic fluorescent probes for the isolation of hybrid cells in flow cytometry.
[Anti-atherosclerotic properties of eicosapentaenoic acid: clinico-experimental study]
[Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease]
Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture.
Antiatherosclerotic effects of calcium antagonists. Study in human aortic cell culture.
[Interactions of low density lipoproteins with elastin in the intima and media from the intact and atherosclerotic human aorta]
Evaluation of cell proliferation in human atherosclerotic lesions.
[Use of allikor for the normalization of fibrinolysis and hemostasis in patients with chronic cerebrovascular diseases]
The content of lipoperoxidation products in normal and atherosclerotic human aorta.
Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.
[Hypotensive effect of long-acting garlic tablets allicor (a double-blind placebo-controlled trial)]
Human plasma trans-sialidase donor and acceptor specificity.
Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions: Atherosclerosis
[Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis]
Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography.
Low ionic strength promotes association of circulating modified LDL in human blood.
Antigenic differences between apo-B in native and circulating modified low-density lipoproteins.
Triggerlike stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells.
[Incidence among men of atherogenic potential of the serum detected in a culture of mouse peritoneal macrophages]
[Low density lipoproteins isolated from the blood of patients with ischemic heart disease induce accumulation of lipids in human aortic intima cells]
Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red cells.
Peritoneal macrophages: a model for detecting atherogenic potential in patients' blood serum.
Insolubilization of low density lipoprotein induces cholesterol accumulation in cultured subendothelial cells of human aorta.
[Peritoneal macrophages as a model for the study of the atherogenic potential of the blood serum]
[The use of freeze fracturing in combination with light, scanning and transmission electron microscopy for studying the structure of the normal and atherosclerotically altered human aortic intima]
[Atherogenic potential of blood serum in patients with type I diabetes mellitus]
[Atherogenic properties of blood serum in children with type I diabetes mellitus]
[Effect of squid liver fat and krill meat on blood serum atherogenicity in patients with type I diabetes mellitus]
[The antiatherosclerotic effect of verapamil in a cell culture of human aortic intima]
[Atherogenic effect of sugar-reducing drugs of the sulfonylurea group and its elimination using papaverine chloride]
[Atherogenic properties of oral sugar-reducing sulfonylurea derivatives]
Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease.
Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.
Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease.
[Immunocytochemical study to localize a scavenger receptor in human aorta smooth muscle cells]
[Multiple modifications of low density lipoproteins in blood of patients with atherosclerosis]
[Intercellular communication studied by using the gap junctions in a primary cell culture of human aortic intima]
Diagnostic value of immune cholesterol as a marker for atherosclerosis.
Gap junctional communication in primary culture of cells derived from human aortic intima.
Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
Atherogenic modified LDL in diabetes.
[Direct antiatherogenic effect of garlic]
Characteristics of low density lipoprotein isolated from circulating immune complexes.
[Multiply-modified disialyated low-density lipoproteins: physico-chemical properties]
Low density lipoprotein-containing circulating immune complexes have better prognostic value in carotid intima-media thickness progression than other lipid parameters.
Association of the level of heteroplasmy of the 15059G>A mutation in the MT-CYB mitochondrial gene with essential hypertension.
Effect of lipoprotein(a) on lipid metabolism of cultured human intimal aortic cells.
Anti-atherosclerotic therapy based on botanicals.
Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.
Lipoprotein immune complexes and their role in atherogenesis
Changes of mitochondria in atherosclerosis: possible determinant in the pathogenesis of the disease.
Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages.
Changes in levels of gene expression in human aortal intima during atherogenesis.
Heterogeneity of smooth muscle cells in embryonic human aorta.
Vascular Extracellular Matrix in Atherosclerosis
Changes of lysosomes in the earliest stages of the development of atherosclerosis.
Trihydroxyoctadecadienoic acids exhibit antiatherosclerotic and antiatherogenic activity.
Diagnostic and prognostic value of low density lipoprotein-containing circulating immune complexes in atherosclerosis.
[Decrease in atherogenicity of blood serum in vitro under the effect of polyunsaturated phosphatidylcholine micelles].
Adult human aortic cells in primary culture: heterogeneity in shape: Heart and Vessels
[Interaction of native and modified low density lipoprotein with intimal cells in atherosclerotic lesion].
Direct anti-atherosclerosis-related effects of garlic.
Dendritic cells: A double-edge sword in atherosclerotic inflammation.
Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay.
Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response.
Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
[Protein-bound lipids in human low density lipoproteins]
Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro: Atherosclerosis
On the role of cyclic nucleotides in the pathogenesis of human atherosclerosis.
Is prostacyclin a major prostaglandin produced by endothelial cells in culture?
Disorders in the system of cyclic nucleotides in atherosclerosis: cyclic AMP and cyclic GMP content and activity of related enzymes in human aorta.
Comparative investigations of the reoccluded distal anastomosis, the spontaneous atherosclerotic plaque and the normal intima of the human femoral artery.
Low-density lipoprotein apheresis and regression of atherosclerotic plaque in vitro.
[Local prevention of thrombosis in the dog carotid artery using magnetically concentrated erythrocytes loaded with aspirin]
[Comparison of 2 methods of flow cytofluorometric analysis of epithelial cells in the diagnosis of uterine cervix cancer]
Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells.
Trapidil derivatives as potential antiatherosclerotic drugs.
Association of low-density lipoprotein with particulate connective tissue matrix components enhances cholesterol accumulation in cultured subendothelial cells of human aorta.